Dyne Therapeutics, Inc. (DYN)
15.44
+0.24
(+1.58%)
USD |
NASDAQ |
Oct 05, 16:00
15.44
0.00 (0.00%)
After-Hours: 20:00
Dyne Therapeutics Market Cap : 2.558B for Oct. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 2.558B |
| October 02, 2026 | 2.518B |
| October 01, 2026 | 2.621B |
| September 30, 2026 | 2.669B |
| September 29, 2026 | 2.686B |
| September 28, 2026 | 2.707B |
| September 25, 2026 | 2.656B |
| September 24, 2026 | 2.735B |
| September 23, 2026 | 2.689B |
| September 22, 2026 | 2.840B |
| September 21, 2026 | 2.836B |
| September 18, 2026 | 2.835B |
| September 17, 2026 | 2.992B |
| September 16, 2026 | 2.867B |
| September 15, 2026 | 2.966B |
| September 14, 2026 | 3.068B |
| September 11, 2026 | 3.017B |
| September 10, 2026 | 3.052B |
| September 09, 2026 | 3.179B |
| September 08, 2026 | 3.365B |
| September 04, 2026 | 4.022B |
| September 03, 2026 | 4.133B |
| September 02, 2026 | 4.165B |
| September 01, 2026 | 4.158B |
| August 31, 2026 | 4.213B |
| Date | Value |
|---|---|
| August 28, 2026 | 4.153B |
| August 27, 2026 | 4.322B |
| August 26, 2026 | 4.367B |
| August 25, 2026 | 4.364B |
| August 24, 2026 | 4.306B |
| August 21, 2026 | 4.324B |
| August 20, 2026 | 4.304B |
| August 19, 2026 | 4.437B |
| August 18, 2026 | 4.307B |
| August 17, 2026 | 4.332B |
| August 14, 2026 | 4.258B |
| August 13, 2026 | 4.301B |
| August 12, 2026 | 4.336B |
| August 11, 2026 | 4.425B |
| August 10, 2026 | 4.390B |
| August 07, 2026 | 4.349B |
| August 06, 2026 | 4.288B |
| August 05, 2026 | 4.336B |
| August 04, 2026 | 4.302B |
| August 03, 2026 | 4.182B |
| July 31, 2026 | 4.172B |
| July 30, 2026 | 4.263B |
| July 29, 2026 | 4.158B |
| July 28, 2026 | 4.291B |
| July 27, 2026 | 4.246B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Neurocrine Biosciences, Inc. | 14.65B |
| Agenus, Inc. | 372.03M |
| Amgen, Inc. | 217.85B |
| BioCryst Pharmaceuticals, Inc. | 2.068B |
| Imunon, Inc. | 5.786M |
Market Cap Related Metrics
| Price to Book Value | 3.643 |
| Price | 15.44 |
| Earnings Yield | -21.58% |